More than 40 percent of American teens are now getting vaccinated against human papillomavirus (HPV). But, despite HPV infection being associated with reduced semen quality and lower pregnancy rates, there is still public ...
Sep 19, 2017
0
675
Adjuvants are often included in vaccines to stimulate the immune system and so make a vaccine more effective. Now an A*STAR team, led by Alessandra Mortellaro from the Singapore Immunology Network, has explained a new immune ...
Jun 28, 2017
1
1
Researchers from New Zealand's University of Otago have gained fresh insights into how one of the main viruses that cause cervical cancer evades its hosts' immune systems.
Oct 6, 2016
0
0
The number of cancers associated with the human papillomavirus (HPV) is on the rise in the United States, reaching nearly 39,000 each year, a US government report said Thursday.
Jul 7, 2016
0
2
Expanding human papillomavirus (HPV) vaccination programs to include males in Canada will help protect them against HPV-related cancers, according to an analysis published in CMAJ (Canadian Medical Association Journal).
Apr 25, 2016
0
1
A Yale-led study finds that a new vaccine for human papillomavirus (HPV) would significantly reduce both cervical cancer incidence and healthcare costs if states coordinated policies to improve coverage.
Apr 18, 2016
0
10
Human papillomavirus (HPV) vaccination stimulates robust and sustained immune responses in girls and young women with chronic kidney disease (CKD) and those on dialysis, but less optimal responses to the vaccine were observed ...
Apr 7, 2016
0
1
Most cancers caused by the human papillomavirus (HPV) are preventable with a vaccine. Yet the infection is responsible for 27,000 cancer diagnoses each year in the U.S.
Feb 3, 2016
0
6
Preliminary results from a survey of 192 Oakland University undergraduate female students in Auburn Hills, Michigan, revealed that although a vast majority of them are aware of the human papillomavirus vaccine (HPV), about ...
Jun 1, 2015
2
11
Men benefit indirectly from vaccinating girls against human papillomavirus (HPV), but remain at risk of cancers associated with the virus, finds a study from The Netherlands published in The BMJ this week.
May 12, 2015
1
18
